Search

everythinglearnresearchcommunity

for

Search:↓

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

GTx-024 and Danazol affect the uterus like DHT, while GTx-007 has little impact.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Blocking Oncostatin M's role in the JAK-STAT pathway can stimulate hair growth in mice.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

Myoblast transplantation shows promise for treating various muscle and heart conditions.

Dihydrotestosterone (DHT) increases oil production in skin cells by activating mTOR, and mTOR inhibitors can reduce this effect.

Ovulation inhibitors effectively treat menstrual issues and improve fertility but can have side effects.

LncRNAs play a crucial role in muscle regulation and could help develop treatments for Duchenne muscular dystrophy.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

BMS-470539 reduces skin fibrosis and inflammation.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

Pro-IGF-II improves muscle repair in old mice.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Certain inhibitors slow down plant growth by causing early cell specialization without changing the cell development pattern.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Overexpressing noggin in mice causes severe osteoporosis.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Ishige sinicola extract may help prevent muscle atrophy through its antioxidant and anti-inflammatory effects.

Lower levels of MYLK and CALD1 in bladder cancer and osteosarcoma are linked to worse survival rates.

Botulinum toxin A can help improve thin endometrium and embryo implantation.